問題詳情

164. Double-hit彌漫性大B細胞淋巴瘤(DLBCL)預後很差,這些病人的淋巴瘤細胞有那兩個基因重組?
(A) MYC, BCL2
(B) BCL2, BCL6
(C) MYC, MCL1
(D) BCL2, MCL1
(E) MYC, BCL1

參考答案

答案:A
難度:計算中-1
書單:沒有書單,新增

用户評論

【用戶】.

【年級】大三上

【評論內容】1. DLBCL consists of a diffuse proliferation of large, atypical lymphocytes with a high proliferative index. These cells typically express the B-cell antigens CD19, CD20, and CD79a. Expression of CD10 and BCL6 is consistent with the tumor cell being of germinal center origin 2. BCL2 is overexpressed in anywhere from 25 to 80% of DLBCL, whereas BCL6 is positive in more than two-thirds of cases, either as the result of translocations, gain of copy number, or promoter mutations. MYC is rearranged in 10% of DLBCLs, and ~20% of MYC-rearranged cases have concurrent BCL2 or BCL6 rearrangements, a combination referred to as “double-hit lymphoma.” These double-hit lymphomas are associated with an extremely poor prognosis with a median OS of only 12–18 months.